SMMT
Summit Therapeutics Inc
$21.21
Earnings Summary
Revenue | $0Mn |
Net Profits | $-60.39Mn |
Net Profit Margins | -Inf% |
Highlights
Summit Therapeutics Inc’s revenue fell -100% since last year same period to $0Mn in the Q2 2024. On a quarterly growth basis, Summit Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.
Summit Therapeutics Inc’s net profit fell -310.31% since last year same period to $-60.39Mn in the Q2 2024. On a quarterly growth basis, Summit Therapeutics Inc has generated -38.9% fall in its net profits since last 3-months.
Summit Therapeutics Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q2 2024. On a quarterly growth basis, Summit Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Summit Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.06 |
EPS Estimate Current Year | -0.06 |
Highlights
Summit Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.06 - a 0% jump from last quarter’s estimates.
Summit Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.06.
Key Ratios
Key ratios of the Summit Therapeutics Inc post its Q2 2024 earnings
Earning Per Share (EPS) | -0.09 |
Highlights
Summit Therapeutics Inc’s earning per share (EPS) fell -326.54% since last year same period to -0.09 in the Q2 2024. This indicates that the Summit Therapeutics Inc has generated -326.54% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-06 | -0.06 | -0.09 | -50% |
2024-05-01 | -0.06 | -0.06 | 0% |
₹0 US Stocks a/c Opening Fee